Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical MLN2238, Purity: ≥95%, CAS: 1072833-77-2, 10 mg
SDP

Catalog No. 502980076
Encompass_Preferred

A 20S proteasome inhibitor (IC50 = 3.4 nM in a cell-free assay for the β5 subunit) and an active metabolite of MLN9708; selective for the β5 subunit over the β1 and β2 subunits (IC50s = 31 and 3,500 nM, respectively); binds caseinolytic protease P (Kd = 5,700 nM); prevents MRSA-induced hemolysis of isolated ovine erythrocytes (EC50 = 3,600 nM); inhibits the proliferation of A375, H460, HCT116, and HT-29 cells (IC50s = 20, 58, 19, and 52 nM, respectively); inhibits osteoclastogenesis in PBMCs isolated from patients with multiple myeloma (IC50 = 4.8 nM); reduces tumor growth in a CWR22 prostate cancer mouse xenograft model at 14 mg/kg

Catalog No. 50-298-0076 Supplier Cayman Chemical Supplier No. 1838510 MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

A 20S proteasome inhibitor (IC50 = 3.4 nM in a cell-free assay for the β5 subunit) and an active metabolite of MLN9708; selective for the β5 subunit over the β1 and β2 subunits (IC50s = 31 and 3,500 nM, respectively); binds caseinolytic protease P (Kd = 5,700 nM); prevents MRSA-induced hemolysis of isolated ovine erythrocytes (EC50 = 3,600 nM); inhibits the proliferation of A375, H460, HCT116, and HT-29 cells (IC50s = 20, 58, 19, and 52 nM, respectively); inhibits osteoclastogenesis in PBMCs isolated from patients with multiple myeloma (IC50 = 4.8 nM); reduces tumor growth in a CWR22 prostate cancer mouse xenograft model at 14 mg/kg

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.